These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Different α-synuclein prion strains cause dementia with Lewy bodies and multiple system atrophy. Ayers JI; Lee J; Monteiro O; Woerman AL; Lazar AA; Condello C; Paras NA; Prusiner SB Proc Natl Acad Sci U S A; 2022 Feb; 119(6):. PubMed ID: 35115402 [TBL] [Abstract][Full Text] [Related]
10. Replication of multiple system atrophy prions in primary astrocyte cultures from transgenic mice expressing human α-synuclein. Krejciova Z; Carlson GA; Giles K; Prusiner SB Acta Neuropathol Commun; 2019 May; 7(1):81. PubMed ID: 31109379 [TBL] [Abstract][Full Text] [Related]
11. Familial Parkinson's point mutation abolishes multiple system atrophy prion replication. Woerman AL; Kazmi SA; Patel S; Aoyagi A; Oehler A; Widjaja K; Mordes DA; Olson SH; Prusiner SB Proc Natl Acad Sci U S A; 2018 Jan; 115(2):409-414. PubMed ID: 29279394 [TBL] [Abstract][Full Text] [Related]
12. Parkinson's disease and multiple system atrophy have distinct α-synuclein seed characteristics. Yamasaki TR; Holmes BB; Furman JL; Dhavale DD; Su BW; Song ES; Cairns NJ; Kotzbauer PT; Diamond MI J Biol Chem; 2019 Jan; 294(3):1045-1058. PubMed ID: 30478174 [TBL] [Abstract][Full Text] [Related]
13. Silver staining (Campbell-Switzer) of neuronal α-synuclein assemblies induced by multiple system atrophy and Parkinson's disease brain extracts in transgenic mice. Lavenir I; Passarella D; Masuda-Suzukake M; Curry A; Holton JL; Ghetti B; Goedert M Acta Neuropathol Commun; 2019 Sep; 7(1):148. PubMed ID: 31522685 [TBL] [Abstract][Full Text] [Related]
14. Transmissible α-synuclein seeding activity in brain and stomach of patients with Parkinson's disease. Thomzig A; Wagenführ K; Pinder P; Joncic M; Schulz-Schaeffer WJ; Beekes M Acta Neuropathol; 2021 Jun; 141(6):861-879. PubMed ID: 33895878 [TBL] [Abstract][Full Text] [Related]
15. Prion-like propagation of human brain-derived alpha-synuclein in transgenic mice expressing human wild-type alpha-synuclein. Bernis ME; Babila JT; Breid S; Wüsten KA; Wüllner U; Tamgüney G Acta Neuropathol Commun; 2015 Nov; 3():75. PubMed ID: 26612754 [TBL] [Abstract][Full Text] [Related]
16. ɑ-Synuclein strains and the variable pathologies of synucleinopathies. Peelaerts W; Baekelandt V J Neurochem; 2016 Oct; 139 Suppl 1():256-274. PubMed ID: 26924014 [TBL] [Abstract][Full Text] [Related]
17. Comparative analyses of the in vivo induction and transmission of α-synuclein pathology in transgenic mice by MSA brain lysate and recombinant α-synuclein fibrils. Dhillon JS; Trejo-Lopez JA; Riffe C; Levites Y; Sacino AN; Borchelt DR; Yachnis AY; Giasson BI Acta Neuropathol Commun; 2019 May; 7(1):80. PubMed ID: 31109378 [TBL] [Abstract][Full Text] [Related]
18. The G51D SNCA mutation generates a slowly progressive α-synuclein strain in early-onset Parkinson's disease. Lau HHC; Martinez-Valbuena I; So RWL; Mehra S; Silver NRG; Mao A; Stuart E; Schmitt-Ulms C; Hyman BT; Ingelsson M; Kovacs GG; Watts JC Acta Neuropathol Commun; 2023 May; 11(1):72. PubMed ID: 37138318 [TBL] [Abstract][Full Text] [Related]
19. A critical review of the prion hypothesis of human synucleinopathies. Tamgüney G; Korczyn AD Cell Tissue Res; 2018 Jul; 373(1):213-220. PubMed ID: 29116402 [TBL] [Abstract][Full Text] [Related]